FZMD Stock Overview
Manufactures and distributes medical devices in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Fuse Medical, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.06 |
| 52 Week High | US$0.16 |
| 52 Week Low | US$0.016 |
| Beta | -1.03 |
| 11 Month Change | 33.33% |
| 3 Month Change | 30.43% |
| 1 Year Change | -54.75% |
| 33 Year Change | -89.83% |
| 5 Year Change | -72.73% |
| Change since IPO | -95.71% |
Recent News & Updates
Recent updates
Shareholder Returns
| FZMD | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 0% | -1.2% | -1.0% |
| 1Y | -54.8% | 2.5% | 30.3% |
Return vs Industry: FZMD underperformed the US Healthcare industry which returned 2.5% over the past year.
Return vs Market: FZMD underperformed the US Market which returned 30.3% over the past year.
Price Volatility
| FZMD volatility | |
|---|---|
| FZMD Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 7.0% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 15.7% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: FZMD's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine FZMD's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Chris Reeg | www.fusemedical.com |
Fuse Medical, Inc. manufactures and distributes medical devices in the United States. The company offers orthopedic implants, including internal and external fixation products for foot and ankle; upper and lower extremity plating and total joint reconstruction implants; soft tissue fixation and augmentation for sports medicine procedures; and full spinal implants for trauma, degenerative disc disease, and deformity indications. It also provides osteo-biologics and regenerative products, which include human allografts, tendons, synthetic skin and bone substitute materials, and regenerative tissues.
Fuse Medical, Inc. Fundamentals Summary
| FZMD fundamental statistics | |
|---|---|
| Market cap | US$4.22m |
| Earnings (TTM) | US$3.98m |
| Revenue (TTM) | US$18.40m |
1.1x
P/E Ratio0.2x
P/S RatioIs FZMD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| FZMD income statement (TTM) | |
|---|---|
| Revenue | US$18.40m |
| Cost of Revenue | US$6.03m |
| Gross Profit | US$12.38m |
| Other Expenses | US$8.40m |
| Earnings | US$3.98m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.057 |
| Gross Margin | 67.25% |
| Net Profit Margin | 21.61% |
| Debt/Equity Ratio | -958.8% |
How did FZMD perform over the long term?
See historical performance and comparison